Consistent with previous studies, in the present study, SC79 reversed the inhibitory effect of RBM8A knockdown on DDP resistance in BC, pointing out that RBM8A knockdown may alleviate the resistance of BC cells to DDP by constraining AKT/mTOR pathway. This evidence concerns the gene AKT1 and breast cancer.